Clinical Trials Directory

Trials / Completed

CompletedNCT06488690

Early Warning Scores in Pregnant Woman

Effectiveness of Early Warning Scores: Preoperative Period in Pregnant Women

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
304 (actual)
Sponsor
Suleyman Demirel University · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

Our study aims to evaluate the use of early warning scores as a screening tool to predict obstetric mortality and morbidity in pregnant women who will undergo cesarean section.

Detailed description

Our study aims to evaluate the use of early warning scores as a screening tool to predict obstetric mortality and morbidity in pregnant women who will undergo cesarean section. This prospective study included 304 patients undergoing cesarean section at Suleyman Demirel University between April 2022 and April 2023. Physiological parameters were assessed in all 304 pregnant women before the operation. Maternal early warning scores, including modified early obstetric warning score (MEOWS), maternal early warning score (MEWC), and maternal early warning triggers (MEWT), were calculated for each patient. Patients triggering the system were classified as Group 1 (risky patients), while those not triggering the system were classified as Group 2 (risk-free patients).

Conditions

Interventions

TypeNameDescription
OTHERAll patients who were pregnant and underwent cesarean sectionOur study aims to evaluate the use of early warning scores as a screening tool to predict obstetric mortality and morbidity in pregnant women who will undergo cesarean section.

Timeline

Start date
2022-04-01
Primary completion
2023-04-01
Completion
2024-02-01
First posted
2024-07-05
Last updated
2024-07-05

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06488690. Inclusion in this directory is not an endorsement.